Research article · 14 Feb 2025
Conference abstractPublished 2018
New neuro-technologies to assess and treat addiction: Neuro-ethical issues, challenges and responsibilities
Georgetown University Hospital, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Large scale federal agendas such as the war on drugs, decade of the brain (1990-99), decade of pain control and research (2000- 2009) and most recently the ongoing Brain Research through Advancing Innovative Neuro-technology (BRAIN). Initiative have prompted research aimed at elucidating neurological substrates and mechanisms of addiction that may be targeted for preventive and therapeutic intervention. Yet, the current opioid crisis, and epidemiological prevalence of addiction disorder(s) imply that efforts of these programs, while impressive, have been less than successful in reducing the burden of addictive illness and care on patients, families, medicine and society. This has prompted renewed interest in, and calls for the translation of emerging techniques and technologies of brain science to applications in clinical care. However, such calls and incentives evoke a dilemma of pacing and prudence: On one hand, is the pressing need for assessments and interventions that enable more capable assessment, prevention and treatment of addictive disorders. While on the other are concerns for the safety, cost and legal issues that could be incurred by early, if not premature translation into clinical contexts. In this lecture, neuroscientist and neuro-ethicist James Giordano of Georgetown University Medical Center provides an overview of new techniques and technologies in brain science that are being developed for assessing and treating addiction. Technical, ethical, legal and social issues arising from the use of such approaches will be addressed, with emphasis upon articulating solution paths to enable prudent provision of new tools and methods via an ethical risk assessment and mitigation approach. Key elements of healthcare policy and economics that are important, if not necessary for the implementation of such translational enterprises will be defined and discussed.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Immunological Techniques & Infectious Diseases.
Review article · 17 Jan 2025
Vitiligo is a Breakdown of the Melanocyte-Immune Tolerance
Short communication · 25 Sep 2024
Pediatric Infections: A Comprehensive Overview of Common Illnesses and Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Immunological Techniques & Infectious Diseases
- SubjectImmunology & Microbiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “James Giordano”
